NCT01672801View on ClinicalTrials.gov

Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Unexplained InfertilityPolycystic Ovarian SyndromeAnovulatory
Interventions
DRUG

Placebo

oral administration

DRUG

Nimodipine

oral administration

Trial Locations (1)

02451

Boston IVF, Waltham

All Listed Sponsors
collaborator

Village Fertility Pharmacy

INDUSTRY

lead

Boston IVF

OTHER

NCT01672801 - Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT | Biotech Hunter | Biotech Hunter